Medulloblastoma other diagnostic studies: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Mahshid |
||
| Line 17: | Line 17: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Neurology]] | |||
[[Category:Neurosurgery]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Neurology]] | [[Category:Neurology]] | ||
[[Category:Neurosurgery]] | [[Category:Neurosurgery]] | ||
Latest revision as of 02:34, 27 November 2017
|
Medulloblastoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case studies |
|
Medulloblastoma other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Medulloblastoma other diagnostic studies |
|
Risk calculators and risk factors for Medulloblastoma other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]
Overview
Bromodeoxyuridine labeling study may be helpful in the diagnosis of medulloblastoma. An elevated bromodeoxyuridine labeling index is suggestive of a rapid growth rate of medulloblastoma.[1]
Bromodeoxyuridine Labeling Study
- Bromodeoxyuridine labeling study may be helpful in the diagnosis of medullblastoma. An elevated bromodeoxyuridine labeling index is suggestive of a rapid growth rate of medulloblastoma.[1]
- The bromodeoxyuridine labeling index of medulloblastoma is measured between:
- 6.8 to 26.9% on dilute hydrochloric acid hydrolysis in vitro technique
- 7.5 to 28.8% on microwave heating in vitro technique
References
- ↑ 1.0 1.1 Onda K, Davis RL, Edwards MS (1996). "Comparison of bromodeoxyuridine uptake and MIB 1 immunoreactivity in medulloblastomas determined with single and double immunohistochemical staining methods". J Neurooncol. 29 (2): 129–36. PMID 8858517.